Deakin University
Browse

NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN NEWLY DIAGNOSED ELDERLY PATIENTS (PTS) WITH GLIOBLASTOMA (GBM) (NUTMEG): TRIAL IN PROGRESS

Version 2 2024-06-19, 00:50
Version 1 2021-01-12, 15:58
conference contribution
posted on 2024-06-19, 00:50 authored by M Khasraw, K McDonald, S Yip, RG Verhaak, AB Heimberger, M Hall, E Barnes, E Hovey, BM Ellingson, Z Lwin
NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN NEWLY DIAGNOSED ELDERLY PATIENTS (PTS) WITH GLIOBLASTOMA (GBM) (NUTMEG): TRIAL IN PROGRESS

History

Volume

20

Pagination

236-236

Location

Stockholm, SWEDEN

Start date

2018-10-10

End date

2018-10-14

ISSN

1522-8517

eISSN

1523-5866

Language

English

Publication classification

E3 Extract of paper

Title of proceedings

NEURO-ONCOLOGY

Event

13th Meeting of the European-Association-of-Neurooncology (EANO)

Publisher

OXFORD UNIV PRESS INC